middle.news
Tryptamine Therapeutics Launches World-First Trial for Binge Eating Disorder
7:02am on Saturday 1st of November, 2025 AEDT
•
Healthcare
Read Story
Tryptamine Therapeutics Launches World-First Trial for Binge Eating Disorder
7:02am on Saturday 1st of November, 2025 AEDT
Key Points
Regulatory approval secured for TRP-8803 BED trial at Swinburne University
First patient enrolled with dosing expected in December 2025
Exclusive EEG-based brain entropy biomarker collaboration launched
Key clinical appointments strengthen trial and formulation expertise
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TYP
OPEN ARTICLE